FDA Amends OTC Oral Sodium Phosphate Labeling, Warns Of Risks
This article was originally published in The Tan Sheet
Executive Summary
FDA recommends consumers not use OTC oral sodium phosphate for bowel cleansing and says it will amend labeling for the products because of a risk of serious kidney injuries